- Patent Title: Dextromethorphan and guaifenesin syrup formulation or suspension
-
Application No.: US17821134Application Date: 2022-08-19
-
Publication No.: US11931413B2Publication Date: 2024-03-19
- Inventor: Max Spielberg , David Johnson
- Applicant: Genexa Inc.
- Applicant Address: US GA Atlanta
- Assignee: Genexa Inc.
- Current Assignee: Genexa Inc.
- Current Assignee Address: US GA Atlanta
- Agency: Greenberg Traurig LLP
- Agent Nigamnarayan Acharya
- Main IPC: A61K31/00
- IPC: A61K31/00 ; A61K9/00 ; A61K31/167 ; A61K35/644 ; A61K36/074 ; A61K36/235 ; A61K36/35 ; A61K36/736 ; A61K36/88 ; A61K36/9066 ; A61K36/9068 ; A61K47/12 ; A61K47/26 ; A61K47/46 ; A61P11/14
Abstract:
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Public/Granted literature
- US20220387598A1 DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION OR SUSPENSION Public/Granted day:2022-12-08
Information query
